A Phase I PK Similarity Study of Sintilimab by Different Production Process in Advanced or Metastatic NSCLC Patients
Status:
Recruiting
Trial end date:
2021-02-01
Target enrollment:
Participant gender:
Summary
this is a phase I study comparing PK similarity of sintilimab by different production process
(approved versus M1b) in Chinese advanced or metastatic NSCLC patients who have failed or
been intolerant to at least one prior line of standard treatment